论文信息 - Health Care Autonomy of Women Living with HIV.

Health Care Autonomy of Women Living with HIV.

Health Care Autonomy of Women Living with HIV HIV policy discussions have focused on a potential link between dolutegravir-based HIV treatment in pregnant women and neural-tube defects in infants, ...

[1] A. d’Arminio Monforte,et al. Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting , 2019, The Journal of antimicrobial chemotherapy.

[2] R. Shapiro,et al. Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception. , 2018, The New England journal of medicine.

[3] J. Friedman. Editorial In Bed with The Devil: Recognizing Human Teratogenic Exposures , 2017, Birth defects research.

[4] S. Walmsley,et al. Dolutegravir – a review of the pharmacology, efficacy, and safety in the treatment of HIV , 2015, Drug design, development and therapy.

[5] J. Polifka,et al. Evolving knowledge of the teratogenicity of medications in human pregnancy , 2011, American journal of medical genetics. Part C, Seminars in medical genetics.